B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

Analyzing DNA methylation patterns in leukemic cells is helping doctors better assess risk and tailor treatments, making ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

The Jonathan Jaques Children's Cancer Institute at Miller Children's & Women's Hospital was involved in a pivotal Children's Oncology Group study that has reshaped the standard of care for children ...

Huntsman Cancer Institute completed the first successful allogeneic stem cell transplant using cells from a deceased donor.

Two years ago, we introduced you to Tobias and his mother, Charity DeLeon—a brave family thrust into a battle they never ...